Orbifloxacin
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
1-Cyclopropyl-7-[(3s,5r)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| Legal status |
|
| Identifiers | |
| CAS Number |
113617-63-3 |
| ATCvet code | QJ01MA95(WHO) |
| PubChem | CID 60605 |
| ChemSpider |
54631 |
| UNII |
660932TPY6 |
| KEGG |
D08299 |
| ChEMBL |
CHEMBL295433 |
| Chemical data | |
| Formula | C19H20F3N3O3 |
| Molar mass | 395.37 g/mol |
| |
| |
| | |
Orbifloxacin (brand name Orbax) is a fluoroquinolone antibiotic which is approved for use in dogs,[1] marketed by Schering-Plough Animal Health.
See also
References
- ↑ Product Abstract - NADA 141-081. Retrieved on June 23, 2008.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
